Literature DB >> 4589824

Clinical trial with monocomponent lente insulins. Preliminary report.

B Bruni, M D'Alberto, M Osenda, C Ricci, G L Turco.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4589824     DOI: 10.1007/bf00461695

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  12 in total

1.  THE M-VALVE, AN INDEX OF BLOOD-SUGAR CONTROL IN DIABETICS.

Authors:  J SCHLICHTKRULL; O MUNCK; M JERSILD
Journal:  Acta Med Scand       Date:  1965-01

2.  A quantitative estimation of antibodies to exogenous insulin in diabetic subjects.

Authors:  P MOINAT
Journal:  Diabetes       Date:  1958 Nov-Dec       Impact factor: 9.461

3.  Evidence for the insulin-directed specificity of rabbit anti-insulin serum.

Authors:  E R ARQUILLA; A B STAVITSKY
Journal:  J Clin Invest       Date:  1956-05       Impact factor: 14.808

4.  Studies with insulin-binding antibody.

Authors:  S A BERSON; R S YALOW
Journal:  Diabetes       Date:  1957 Sep-Oct       Impact factor: 9.461

5.  Recrystallized insulin for diabetic patients with insulin allergy.

Authors:  J E JORPES
Journal:  Arch Intern Med (Chic)       Date:  1949-04

6.  Radioimmunoelectrophoresis in the determination of insulin binding to IgG.

Authors:  A H Christiansen
Journal:  Horm Metab Res       Date:  1973-05       Impact factor: 2.936

7.  [Experiences with monocomponent insulin treatment].

Authors:  W Korp; R E Levett
Journal:  Wien Klin Wochenschr       Date:  1973-05-04       Impact factor: 1.704

8.  Clinical aspects of insulin--antigenicity.

Authors:  J Schlichtkrull; J Brange; A H Christiansen; O Hallund; L G Heding; K H Jorgensen
Journal:  Diabetes       Date:  1972       Impact factor: 9.461

9.  The antigenicity of pig insulin.

Authors:  T Deckert; E Grundahl
Journal:  Diabetologia       Date:  1970-02       Impact factor: 10.122

10.  Isolation and properties of proinsulin, intermediate forms, and other minor components from crystalline bovine insulin.

Authors:  D F Steiner; O Hallund; A Rubenstein; S Cho; C Bayliss
Journal:  Diabetes       Date:  1968-12       Impact factor: 9.461

View more
  16 in total

1.  Reduction of insulin dose on changing diabetic children from standard to monocomponent insulins.

Authors:  N K Griffin; M A Smith; J D Baum
Journal:  Arch Dis Child       Date:  1979-02       Impact factor: 3.791

2.  The clinical significance of highly purified pig-insulin preparations.

Authors:  T Deckert; O O Andersen; J E Poulsen
Journal:  Diabetologia       Date:  1974-12       Impact factor: 10.122

3.  Serum levels of insulin-binding antibodies in diabetic patients treated with monocomponent insulin.

Authors:  A Czyzyk; J Lawecki; H Rogala; E Miedzińska; A Popik-Hankiewicz
Journal:  Diabetologia       Date:  1974-06       Impact factor: 10.122

4.  The newer insulins.

Authors:  J G Devlin; O Maguire; V Parameswaran
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

Review 5.  Circulating insulin-binding antibodies.

Authors:  A B Kurtz; J D Nabarro
Journal:  Diabetologia       Date:  1980-10       Impact factor: 10.122

6.  Highly purified insulins.

Authors:  K G Alberti; M Nattrass
Journal:  Diabetologia       Date:  1978-08       Impact factor: 10.122

7.  The production and characteristics of anti-insulin, anti-A-component and anti-proinsulin antibodies in patients treated with monocomponent or conventional insulin.

Authors:  S Kawazu; Y Kanazawa; E Miki; M Hayashi; H Sando; H Kajinuma; Y Iwamoto; Y Akanuma; K Kosaka
Journal:  Acta Diabetol Lat       Date:  1979 Oct-Dec

8.  Antibody formation and insulin requirements in diabetic children during treatment with purified commercial pork insulins.

Authors:  B Weber; J Tech; H Schmidt; U Oberdisse
Journal:  Eur J Pediatr       Date:  1978-06-20       Impact factor: 3.183

9.  Insulin binding capacity in patients changed from conventional to highly purified insulins. An indicator of likely response.

Authors:  B E Mustaffa; P R Daggett; J D Nabarro
Journal:  Diabetologia       Date:  1977-08       Impact factor: 10.122

10.  Proinsulin and A-component antibodies in diabetics after long-term monocomponent insulin treatment.

Authors:  B Bruni; S Gamba; G Regis; G L Turco
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.